HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website – founded as a partnership between CHDI and the Coppola Lab at UCLA – is currently a joint development effort by CHDI, Bridlewood Consulting and Rancho BioSciences. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Want to learn more about HDinHD?
| Watch a detailed video overview of HDinHD presented at the 16th Annual HD Therapeutics Conference (April 2021). The video outlines data resources and tools within HDinHD and provides a detailed demonstration of the new HD Explorer tool. |
Read the following publication introducing HDinHD: HDinHD: A Rich Data Portal for Huntington’s Disease Research, J Huntingtons Dis., 10, 405-412
Latest news and publications from around the HD Ecosystem
HDBuzz
- Mirror, Mirror on the Wall: When Self-Awareness Shifts in Huntington’s Disease
- More Than Just Food: The Hidden Challenges of Eating with Huntington’s Disease
- Roche ends two Huntington’s disease drug programmes after disappointing results
- Are we finally getting that PET we’ve always wanted?
- Skyhawk Shares A Closer Look at SKY-0515 Data, Plus A Peek At Expanding US Trial Access
Literature
- The Recommendation Paradox: Perspectives on Genetic Testing in Huntington's Disease Families
- Emotion regulation across disease stages in Huntington's disease gene expansion carriers
- Understanding the cellular architecture of Huntington's disease
- CRISPR-Cas9-based therapies for Huntington's disease and Friedreich's ataxia: mechanisms, advances, and future perspectives
- Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) Is Effective in Reducing Symptoms of Huntington's Disease in Females of the R6/1 Mouse Model
News
- Jesy Nelson's SMA Victory Highlights How Early Diagnosis Can Rewrite the Future ... - Medical Daily
- Inside the fight against the parasite Cyclospora - Science News
- uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix - TradingView
- Is QURE Stock Attractive After Its Rally, Rich Valuation, and Hold? - Yahoo Finance
- uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix - Yahoo Finance




